An international expert consensus conference regarding testosterone deficiency and its treatment was held in Prague, Czech Republic. Participants were invited on the basis of their clinical and/or research expertise with Testosterone Deficiency and represented a broad range of specialties from 11 countries on 4 continents. It included doctors and professors from Mayo Clinic, Cleveland Clinic, Harvard and Yale. The goal was to determine if a consensus could be reached by a broad range of experts on the benefits of testosterone. Nine resolutions were debated, and unanimously approved.
- Testosterone Deficiency is a global public health concern;
- Testosterone deficiency is a well-established, clinically significant medical condition that negatively affects male sexuality, reproduction, general health, and quality of life;
- Testosterone therapy for men with a deficiency is effective, rational, and evidence based;
- There is no Testosterone concentration threshold that reliably distinguishes those who will respond to treatment from those who will not;
- There is no scientific basis for any age-specific recommendations against the use of Testosterone therapy in men;
- The evidence does not support increased risks of cardiovascular events with T therapy;
- The evidence does not support increased risk of prostate cancer with T therapy;
- The evidence supports a major research initiative to explore possible benefits of T therapy for cardiometabolic disease, including diabetes; and
- Symptoms and signs of Testosterone deficiency occur as a result of low levels of testosterone and may benefit from treatment regardless of whether there is an identified underlying disease or condition.
Here is the article in full from Mayo Clinic: http://www.mayoclinicproceedings.org/article/S0025-6196(16)30115-X/fulltext